TFS CAPITAL LLC - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 143 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2016. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2016$37,000
-17.8%
10,536
-11.0%
0.01%
+66.7%
Q1 2016$45,000
-82.8%
11,840
-52.2%
0.01%
-76.0%
Q3 2015$261,000–24,770–0.02%–
 Download
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q2 2016
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders